A Phase 3 interventional study of Food voucher in Diabete Type 2, sponsored by Unity Health Toronto. Recruiting at 1 site in Canada. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2026-02-10.
Sponsored by Unity Health Toronto · Phase 3, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 19 studies in Diabetes Mellitus, Type 2 by Unity Health Toronto — 2 open to participants now, 2 under way, 1 of them phase 3. Diabetes Mellitus, Type 2 · Unity Health Toronto.
Among the 19 studies in Diabetes Mellitus, Type 2 by Unity Health Toronto, this one has the largest planned enrollment of the 14 interventional ones that give a count, is the only one that started in 2023, is the only one in phase 3, and was the 18th registered.
10,403 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,413 are open to participants now.
Browse Diabetes Mellitus, Type 2 studies →2 of the 19 studies in Diabetes Mellitus, Type 2 by Unity Health Toronto are open now, in 1 country. Recruiting first, the newest first:
Unity Health Toronto · Sites in Canada
Ages 18+
By country, each count listing its studies:
Of the 882 Diabetes Mellitus, Type 2 studies recruiting now, 372 (42%) set no upper age limit and 384 (44%) stop at 75 or younger; 52 take children under 18; 202 take healthy volunteers.
This study: 19 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
19 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 4 · Phase 3 1 · Phase 4 3
First in 1989; this study’s year is marked. 1 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 390 is above the median of 80 across 8,372 interventional studies indexed under Diabetes Mellitus, Type 2.
Median enrollment 94 across the 14 interventional studies, 734 across the 4 observational. Of the 11 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Unity Health Toronto is the lead sponsor of 447 studies on the registry; 81 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 1 (20%) have results posted.
2 of the studies in Diabetes Mellitus, Type 2 by Unity Health Toronto that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05776420Phase 3Unity Health TorontoEffect of a Healthy Food Voucher on Blood Glucose Control in People With Type 2 Diabetes or Prediabetes | 2027-04-01 |
| NCT07017270Unity Health TorontoGlucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis | 2027-07 |
Add all 2 to your calendar (.ics) → With an account.
Among the 19 studies in Diabetes Mellitus, Type 2 by Unity Health Toronto, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This randomized controlled trial (RCT) will determine if access to a voucher for healthy foods reduces blood sugar levels among people living on a low income who have type 2 diabetes or elevated blood sugar.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
HbA1c
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Life expectancy
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
$65 monthly voucher for healthy foods (phase 1)
Behavioral: Food voucher
$160 monthly voucher for healthy foods (phase 2)
Behavioral: Food voucher
$40 monthly voucher for healthy foods (phase 2)
Behavioral: Food voucher
A voucher of that can be redeemed for food at grocery stores.
Hemoglobin A1c
Change in hemoglobin A1c
Time frame: 6 months
General health ("In general, how would you rate your health today?")
Self-reported health. Potential responses are: very good, good, moderate, bad, very bad and decline to respond.
Time frame: 6 months
Financial security ("Do you have trouble making ends meet at the end of the month?")
Self-reported financial security
Time frame: 6 months
Food insecurity measured by 6 questions from Household Food Security Survey
Self-reported food insecurity
Time frame: 6 months
Fruit and vegetable consumption
Self-reported fruit and vegetable consumption
Time frame: 6 months
Health care utilization using administrative data
Includes hospitalizations, outpatient visits and primary care visits
Time frame: 6 months
Carotenoid level
Serum caortenoid level
Time frame: 6 months
Plan to share: Yes — We plan to share de-identified individual participant data
Started Mar 2023 (actual). Primary completion is estimated for Apr 2027, 48 months after the start.
Of 87 non-industry phase 3 interventional studies under Diabetes Mellitus, Type 2, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 47. This study's planned 48 months is above that.
Counting every sponsor, half of 525 studies reached it within 20 months; a quarter within 14 and three quarters within 30.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.